Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 856 to 870 of 1362 results for social care

  1. What community-based interventions are effective and cost effective at improving the uptake of, and reducing inequalities in the use of, dental services by groups of adults and children at high risk of poor oral health?

    Non-clinical outcomes should include the use of non-dental health and social care services by children and adults, such as numbers...

    Research recommendation
    Published
    9 June 2015

  2. The consequences and costs of poor transition:- What are the consequences and the costs of young people with ongoing needs not making a transition into adult services, or being poorly supported through the process?

    from children's to adults' services for young people using health or social care services Number NG43 Date issued February 2016

    Research recommendation
    Published
    21 March 2016

  3. Digital health technologies to help manage symptoms of psychosis and prevent relapse in adults and young people: early value assessment (HTG713)

    Early value assessment (EVA) guidance on digital health technologies to help manage symptoms of psychosis and prevent relapse in adults and young people.

    HealthTech guidance
    Published
    25 March 2024
    View recommendations

    Sections for HTG713

  4. Osimertinib for untreated EGFR mutation-positive non-small-cell lung cancer (TA654)

    Evidence-based recommendations on osimertinib (Tagrisso) for untreated locally advanced or metastatic epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer in adults.

    Technology appraisal guidance
    Published
    14 October 2020

    Sections for TA654

  5. Single technology appraisal and highly specialised technologies evaluation: User guide for company evidence submission template (PMG24)

    This is the user guide for submission of evidence to the National Institute for Health and Care Excellence (NICE) as part of the single technology appraisal and highly specialised technologies evaluations process. It explains what information NICE requires and the format in which it should be presented

  6. Cannabidiol with clobazam for treating seizures associated with Dravet syndrome (TA614)

    Evidence-based recommendations on cannabidiol (Epidyolex) with clobazam for seizures associated with Dravet syndrome in people aged 2 years and older.

    Technology appraisal guidance
    Published
    18 December 2019
    View recommendations

    Sections for TA614

  7. Gilteritinib for treating relapsed or refractory acute myeloid leukaemia (TA642)

    Evidence-based recommendations on gilteritinib (Xospata) for relapsed or refractory FLT3-mutation-positive acute myeloid leukaemia in adults.

    Technology appraisal guidance
    Published
    12 August 2020
    View recommendations

    Sections for TA642

  8. Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoea (TA777)

    Evidence-based recommendations on solriamfetol (Sunosi) for treating excessive daytime sleepiness caused by obstructive sleep apnoea in adults.

    Technology appraisal guidance
    Published
    9 March 2022
    View recommendations

    Sections for TA777

  9. Supporting young people to manage their conditions:- What is the relationship between transition and subsequent self-management?

    from children's to adults' services for young people using health or social care services Number NG43 Date issued February 2016

    Research recommendation
    Published
    21 March 2016

  10. Berotralstat for preventing recurrent attacks of hereditary angioedema (TA738)

    Evidence-based recommendations on berotralstat (Orladeyo) for preventing recurrent attacks of hereditary angioedema in people 12 years and older.

    Technology appraisal guidance
    Published
    20 October 2021
    View recommendations

    Sections for TA738

  11. Fertility problems: assessment and treatment (CG156)

    This guideline covers diagnosing and treating fertility problems. It aims to reduce variation in practice and improve the way fertility problems are investigated and managed.

    Clinical guideline
    Last updated
    6 September 2017
    View recommendations

    Sections for CG156

  12. One-piece closed bags for colostomies: late-stage assessment (HTG754)

    Late stage assessment (LSA) guidance on one-piece closed bags for colostomies

    HealthTech guidance
    Published
    10 July 2025
    View recommendations

    Sections for HTG754

  13. Transition support for young adults:- What approaches to providing transition support for those who move from child to adult services are effective and/or cost-effective?

    from children's to adults' services for young people using health or social care services Number NG43 Date issued February 2016

    Research recommendation
    Published
    21 March 2016

  14. Holistic assessment in the community:- What is the clinical and cost effectiveness of a community holistic assessment and intervention for people living with high levels of multimorbidity?

    are relevant to patients and health and social care services (for example, quality of life, hospital and care home...

    Research recommendation
    Published
    18 October 2016

  15. What training, support or interventions help to reduce caring-related accidents or incidents?

    understanding of the health condition, disability or needs of the person they care for, so the committee recommended carer-specific...

    Research recommendation
    Published
    10 February 2020